Welcome to LookChem.com Sign In|Join Free
  • or
5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-2'-C-methyluridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1244762-79-5

Post Buying Request

1244762-79-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1244762-79-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1244762-79-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,4,7,6 and 2 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1244762-79:
(9*1)+(8*2)+(7*4)+(6*4)+(5*7)+(4*6)+(3*2)+(2*7)+(1*9)=165
165 % 10 = 5
So 1244762-79-5 is a valid CAS Registry Number.

1244762-79-5Downstream Products

1244762-79-5Relevant academic research and scientific papers

2'-deoxy-2'-fluoro-2'-C-methyluracil nucleoside phosphoramidite monomer and synthesis method thereof

-

Paragraph 0024, (2019/01/08)

The invention discloses a 2'-deoxy-2'-fluoro-2'-C-methyluracil nucleoside phosphoramidite monomer and a synthesis method thereof. The compound adopts a structural general formula as follows: FORMULA.The synthesis method comprises the following step: perfo

STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENT

-

Paragraph 0724-0725, (2016/02/12)

5′-Deuterated nucleosides and nucleotides and modifications thereof are provided for use in medical therapies, including as antiviral, anti-tumor and anti-neoplastic agents. In one embodiment, compounds, methods and uses are provided for the treatment of

DEUTERATED NUCLEOSIDE/TIDE DERIVATIVES

-

Page/Page column 46, (2016/06/01)

The present invention provides nucleoside phosphoramidate compounds of Formula (I), where R1, R2a, R2b, R4, R5a, R5b, Rb5, Rb6 and D are as defined herein. The invention further includes pharmaceutical compositions comprising a compound of Formula (I), methods of use of these compounds for treating a viral infection, and methods of producing these compounds.

Synthesis and anti-HCV activity of 3′,4′-oxetane nucleosides

Chang, Wonsuk,Du, Jinfa,Rachakonda, Suguna,Ross, Bruce S.,Convers-Reignier, Serge,Yau, Wei T.,Pons, Jean-Francois,Murakami, Eisuke,Bao, Haiying,Steuer, Holly Micolochick,Furman, Phillip A.,Otto, Michael J.,Sofia, Michael J.

scheme or table, p. 4539 - 4543 (2010/11/03)

Hepatitis C virus afflicts approximately 180 million people worldwide and currently there are no direct acting antiviral agents available to treat this disease. Our first generation nucleoside HCV inhibitor, RG7128 has already established proof-of-concept

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1244762-79-5